Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
Experimental and Therapeutic Medicine
|
November 14, 2013
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Ryuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Pathology International
|
January 9, 2010
Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging
Rin Yamaguchi, Maki Tanaka, Toshiro Yokoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 17, 2026
[A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy]
Masami Hattori, Hitomi Mori, Torakichi Shingo, et al.
Journal of Cellular Biochemistry
|
February 24, 2012
Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways
Naoko Seki, Uhi Toh, Koji Kawaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 19, 2010
[A case of breast meningeal carcinomatosis caused by trastuzumab treatment as adjuvant chemotherapy]
Hiroki Takahashi, Teruhiko Fujii, Yuka Inoue, et al.
Cancer Science
|
July 28, 2015
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele
Shinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Breast Cancer Research : BCR
|
July 5, 2014
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
Ryuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Cancer Research
|
November 24, 2016
Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression
Tomohiro Shibata, Kosuke Watari, Hiroto Izumi, et al.
Cancer Science
|
February 9, 2017
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> allele
Shinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Breast Cancer Research and Treatment
|
March 31, 2023
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
Experimental and Therapeutic Medicine
|
November 14, 2013
Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy
Ryuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Pathology International
|
January 9, 2010
Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging
Rin Yamaguchi, Maki Tanaka, Toshiro Yokoyama, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
January 17, 2026
[A Case of Hormone Receptor-Positive, HER2-Negative Metastatic Recurrent Breast Cancer Successfully Treated with Capivasertib and Fulvestrant in Late-Line Therapy]
Masami Hattori, Hitomi Mori, Torakichi Shingo, et al.
Journal of Cellular Biochemistry
|
February 24, 2012
Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways
Naoko Seki, Uhi Toh, Koji Kawaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
August 19, 2010
[A case of breast meningeal carcinomatosis caused by trastuzumab treatment as adjuvant chemotherapy]
Hiroki Takahashi, Teruhiko Fujii, Yuka Inoue, et al.
Cancer Science
|
July 28, 2015
Immunological evaluation of peptide vaccination for cancer patients with the HLA-A26 allele
Shinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Breast Cancer Research : BCR
|
July 5, 2014
Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
Ryuji Takahashi, Uhi Toh, Nobutaka Iwakuma, et al.
Cancer Research
|
November 24, 2016
Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression
Tomohiro Shibata, Kosuke Watari, Hiroto Izumi, et al.
Cancer Science
|
February 9, 2017
Immunological evaluation of peptide vaccination for cancer patients with the HLA -A11<sup>+</sup> or -A33<sup>+</sup> allele
Shinjiro Sakamoto, Satoko Matsueda, Shinzo Takamori, et al.
Breast Cancer Research and Treatment
|
March 31, 2023
Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)
Kenichi Watanabe, Naoki Niikura, Yuichiro Kikawa, et al.
Page
of 7